Shilpa Pharma is a leading Contract Development and Manufacturing Organization (CDMO) in India, delivering high-quality, end-to-end solutions for pharmaceutical innovators worldwide. With decades of expertise in oncology APIs, formulations, peptides, polymers, and biologics, we support clients at every stage—from early development to commercial-scale manufacturing. Our comprehensive CDMO services include formulation development, process optimization, analytical support, and scalable manufacturing, ensuring a seamless transition from concept to market-ready products.
Backed by state-of-the-art, regulatory-compliant facilities and a team of 100+ R&D specialists along with 1500+ skilled professionals, Shilpa Pharma combines scientific excellence with operational reliability. Our commitment to innovation, quality, and efficiency makes us the trusted partner for pharmaceutical companies seeking flexible, scalable, and reliable solutions for drug development and manufacturing.

From simple to multi-step syntheses, we deliver precision-built CDMO solutions tailored to your needs.

Expertise in solid and solution-phase synthesis, cryogenic, and high-pressure reactions.

Offering non-GMP to GMP manufacturing — from lab-scale to commercial production.
Leading the Way in Pharma Innovation

Established

R&D workforce

Team size

Manufacturing site

Audits

Customers

Projects
At Shilpa Pharma, our custom CDMO manufacturing services in India are designed to deliver precision, quality, and compliance at every stage. Equipped with cutting-edge technology and certified by leading regulatory authorities, our facilities handle everything from raw material sourcing to final packaging under strict quality protocols.
We go beyond just meeting standards — we ensure international benchmarks are exceeded, enabling you to bring safe, effective, and high-quality products to the global market with confidence.
Key Highlights:
At Shilpa Pharma, our custom development services are focused on creating innovative, compliant, and scalable pharmaceutical solutions tailored to your needs. Leveraging advanced R&D capabilities and GMP-certified facilities, we support every stage — from route scouting and process optimization to formulation development and pilot-scale manufacturing.
We ensure that your products meet not just regulatory standards but also global quality expectations, helping you bring safe, effective, and market-ready medicines to patients worldwide.
At Shilpa Pharma, we provide comprehensive Contract Development and Manufacturing Services (CDMO) in India that help global pharmaceutical companies bring high-quality products to market faster and more efficiently. As a leading global CDMO in pharma, we specialize in drug substance manufacturing, formulation development, and contract manufacturing solutions that meet the highest regulatory and quality standards.
Whether you are looking for end-to-end CDMO services in India or specific CDMO biologics services, Shilpa Pharma offers flexible, scalable, and cost-effective solutions tailored to your development and commercial needs
A Contract Development and Manufacturing Organization (CDMO) is a partner that provides comprehensive drug development and manufacturing services to pharmaceutical and biotech companies. CDMOs handle the entire lifecycle—from formulation development, clinical trial materials, to commercial-scale manufacturing—allowing clients to focus on innovation, marketing, and patient care.
By working with a trusted CDMO pharma company, you gain access to cutting-edge infrastructure, scientific expertise, and regulatory experience that ensures quality and speed to market.
India has become a preferred destination for CDMO & contract manufacturing in the pharma industry due to its strong scientific talent, cost efficiency, and robust regulatory framework. Here’s why international pharmaceutical firms choose CDMO services in India:
High-Quality Standards: Indian CDMOs comply with stringent global regulatory norms, ensuring top-quality output.
Cost Advantage: India offers competitive pricing without compromising on technology or quality.
Skilled Workforce: A large pool of experienced scientists and chemists with expertise in R&D and manufacturing.
Strong Regulatory Ecosystem: Facilities approved by international agencies such as USFDA, EU GMP, and others.
Integrated Capabilities: From discovery to delivery, Indian CDMOs like Shilpa Pharma provide seamless, end-to-end support.
Choosing a reliable CDMO pharma company in India offers multiple benefits:
Reduced Time-to-Market – Accelerate product launch through efficient project execution.
Scalability – Flexible capacity for both small-scale and large-volume production.
Regulatory Expertise – Comprehensive understanding of global compliance standards.
Innovation Support – Access to advanced technology and R&D infrastructure.
Risk Reduction – Shared technical and regulatory responsibilities with an experienced partner.
As a globally recognized CDMO in India, Shilpa Pharma’s manufacturing facilities meet the highest international quality standards. Our plants hold multiple global certifications and approvals that reflect our dedication to excellence and compliance.
Our facilities are:
USFDA Approved (United States Food & Drug Administration)
EU GMP Certified (European Union Good Manufacturing Practice)
ANVISA Approved (Brazilian Health Regulatory Agency)
COFEPRIS Approved (Mexico)
TGA Certified (Australia)
PMDA Approved (Japan)
KFDA Certified (South Korea)
These certifications position Shilpa Pharma as a trusted CDMO pharma company for both regulated and semi-regulated markets around the world.
As one of the top 3 best CDMO service providers in the world, Shilpa Pharma stands out for its commitment to quality, innovation, and global excellence. We are a leading CDMO pharma company in India, offering a wide range of contract development and manufacturing services across therapeutic segments and dosage forms.
Our key strengths include:
Comprehensive Expertise: From CDMO formulation development to drug substance manufacturing, we deliver complete pharmaceutical solutions.
Advanced Infrastructure: State-of-the-art facilities equipped with the latest technologies for research, development, and large-scale production.
Global Reach: Supplying to regulated and semi-regulated markets worldwide.
Quality Commitment: Every product is backed by strict quality control and global regulatory compliance.
Collaborative Approach: We work closely with partners to ensure transparency, flexibility, and timely delivery.
Shilpa Pharma is the preferred CDMO services for companies across China, Japan, Europe, and other international markets. This global trust is built on our consistent product quality, robust compliance framework, and responsive customer service.
ooking for a contract manufacturing organization in India that combines innovation, compliance, and reliability?
Partner with Shilpa Pharma – your global partner for end-to-end CDMO services in India.
Get our capability overview via email